Ask AI
ProCE Banner Activity

Primary Biliary Cholangitis in the Spotlight: A Retrospective on EASL 2025

Clinical Thought

EASL 2025 may be over, but read on to find out what studies and analyses are still on my mind, including symptom-directed therapies for PBC, and how we should be thinking of PBC and other liver-related conditions in coexistence with each other, rather than in isolation.

Released: July 24, 2025

Expiration: July 23, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc. and Ipsen Biopharmaceuticals, Inc.

Gilead Sciences, Inc.

Ipsen Biopharmaceuticals Inc

Faculty Disclosure

Primary Author

Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH: consultant/advisor/speaker: Gilead, Ipsen.